India Molecular Diagnostics Market By Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing), By Technology (PCR, In-situ Hybridization, Chips and Microarrays, Mass Spectrometry, Sequencing, Others), By End User (Hospitals, Academic & Reference Laboratories), By Region, Competition, Forecast & Opportunities, FY 2026
India molecular diagnostics market stood at an estimated $ 920 million in FY 2020 and is projected to grow at a CAGR of around 10% until FY 2026, predominantly on account of rising cases of fatal and chronic diseases. Moreover, spread of COVID-19 pandemic is expected to create more opportunities, which is anticipated to drive market growth during the forecast period. Furthermore, government initiatives of raising funds for the country’s molecular department is also expected to positively influence the market in the coming years. However, since the department requires high competence and professional skillset, absence of the same can pose a hurdle. Also, with over 25% of the country’s population being below poverty line and the rest of the population is either middle-class or lower middle-class, lack of funds and high cost of molecular diagnostics is also expected to hinder the growth of the market during the forecast period.
India molecular diagnostics market is segmented into application, technology, end user, and region. Based on application, the market is further fragmented into infectious disease, blood screening, genetic testing and oncology testing, out of which oncology testing segment is expected to dominate the market until FY 2026, followed by the infectious disease segment.
Major players operating in India molecular diagnostics market include Roche Diagnostics India Pvt Ltd, Abbott India Limited, Qiagen India Pvt Ltd, bioMérieux India, Becton Dickinson Private Limited, Biocartis, Bio-Techne India Private Limited, Danaher, Bio-Rad laboratories India Pvt.Ltd, Cleaver Scientific, etc.
Years considered for this report:
Historical Years: FY2016 - FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022 - FY2026
Objective of the Study:
• To analyze and estimate the market size of India molecular diagnostics market from FY2016 to FY2020.
• To estimate and forecast the market size of India molecular diagnostics market from FY2021 to FY2026.
• To classify and forecast India molecular diagnostics market based on application, technology, end user, region and company.
• To identify dominant region or segment in the India molecular diagnostics market.
• To identify drivers and challenges for India molecular diagnostics market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India molecular diagnostics market.
• To conduct pricing analysis for India molecular diagnostics market.
• To identify and analyze the profile of leading players operating in India molecular diagnostics market.
• To identify key sustainable strategies adopted by market players in India molecular diagnostics market.
It performed both primary as well as exhaustive secondary research for this study. Initially, It sourced a list of service providers across the country. Subsequently, It conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, It could include the service providers which could not be identified due to the limitations of secondary research. It analyzed the service providers, distribution channels and presence of all major players across the country.
It calculated the market size of India molecular diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. It sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by It.
Key Target Audience:
• End users, hospitals, and laboratories
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances related to molecular diagnostics
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
In this report, India molecular diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Market, By Application:
o Infectious disease
o Blood screening
o Genetic testing
o Oncology testing
• Market, By Technology:
o In-situ hybridization
o Chips and microarrays
o Mass spectrometry
• Market, By End User:
o Academic & Reference Laboratories
• Market, By Region:
Company Profiles: Detailed analysis of the major companies present in India molecular diagnostics market.
With the given market data, It offers customizations according to a company’s specific needs. The following customization options are available for the report:
• Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. India Molecular Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Application (Infectious disease, Blood screening, Genetic testing, Oncology testing)
5.2.2. By Technology (PCR, In-situ hybridization, Chips and microarrays, Mass spectrometry, Sequencing, Others)
5.2.3. By End User (Hospitals, Academic & Reference Laboratories)
5.2.4. By Region (North, East, West, South)
5.2.5. By Company (FY2020)
5.3. Market Attractiveness Index
6. India PCR Technology Based Molecular Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application
6.2.2. By End User
7. India In-Situ Hybridization Molecular Diagnostics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By End User
8. India Chips and microarrays Molecular Diagnostics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By End User
9. India Mass spectrometry Molecular Diagnostics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By End User
10. India Sequencing Molecular Diagnostics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By Technology
10.2.3. By End User
11. Market Dynamics
12. Market Trends & Developments
13. Policy & Regulatory Landscape
14. India Economic Profile
15. Competitive Landscape
15.1. Competition Outlook
15.2. Company Profiles
15.2.1. Roche Diagnostics India Pvt Ltd
15.2.2. Abbott India Limited
15.2.3. Qiagen India Pvt Ltd
15.2.4. bioMérieux India Pvt. Ltd.
15.2.5. Becton Dickinson Private Limited
15.2.6. Biocartis Group
15.2.7. Bio-Techne India Private Limited
15.2.8. Danaher Corporation
15.2.9. Bio-Rad laboratories India Pvt.Ltd
15.2.10. Cleaver Scientific
16. Strategic Recommendations
List Of Figures
Figure 1: India Molecular Diagnostic Market Size, By Value (USD Million), FY2016-FY2026
Figure 2: India Molecular Diagnostic Market Share, By Product Type, FY2016-FY2026
Figure 3: India Molecular Diagnostic Market Size, By PCR, FY2016-FY2026
Figure 4: India Molecular Diagnostic Market Size, By Mass Spectrophotometer, FY2016-FY2026
Figure 5: India Molecular Diagnostic Market Size, By Sequencing, FY2016-FY2026
Figure 6: India Molecular Diagnostic Market Size, By Others, FY2016-FY2026
Figure 7: India Molecular Diagnostic Market Share, By Technology, FY2016-FY2026
Figure 8: India Molecular Diagnostic Market Share, By Application, FY2016-FY2026
Figure 9: India Molecular Diagnostic Market Share, By End-User, FY2016-FY2026
Figure 10: India Molecular Diagnostic Market Share, By Company, FY2016-FY2026
Figure 11: India Molecular Diagnostic Market Share, By Region, FY2016-FY2026
Figure 12: India Molecular Diagnostic Market Share Attractiveness Index, By Type, By Value, FY2016-FY2026F
2024 India Nucleic Acid Testing (NAT) Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. The reportView Report
2024 India Virology and Bacteriology Market for over 100 Tests: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Emerging Technologies, Instrumentation, Opportunities
This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the infectious disease testing market during the next five years.TheView Report
2020 US Molecular Diagnostics Market: Supplier Sales and Market Shares by Product, Competitive Profiles
This unique report provides US Supplier Sales and market share estimates for major suppliers of molecular diagnostic products.The report also presents strategic assessments of major suppliers and emerging market entrants,View Report
2020 UK Molecular Diagnostics Market: Supplier Sales and Market Shares by Product, Competitive Profiles
This unique report provides UK Supplier Sales and market share estimates for major suppliers of molecular diagnostic products.The report also presents strategic assessments of major suppliers and emerging market entrants,View Report
Fill The Form For Sample Request